Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient
Diosmin
6
Clinical Trials
1
Meta-Analyses
7
PubMed References
Top Conditions Studied with Diosmin
📋 Sample Trials
NCT01532882
Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs
Completed · Phase 3
NCT02134249
Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome
Completed · Phase 2|Phase 3
NCT03413618
Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
Completed · Phase 4
📊 Sample Meta-Analyses
CRD42017078018
Systematic review and meta-analysis of efficacy of diosmin and hesperidin versus aminftones in inflammatory mediators levels decrease and pain scale in chronic venous insufficiency treatment.
insufficiency venous
📚 Sample References
PMID 26361726
Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice
Pharmacol Res · 2015
PMID 33302042
Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis
Phytomedicine · 2021
PMID 33744325
Targeting KEAP1/Nrf2, AKT, and PPAR-γ signals as a potential protective mechanism of diosmin against gentamicin-induced nephrotoxicity
Life Sci · 2021
⚗️ All Ingredient data fields for Diosmin
⚗️ Identity
Name
Diosmin
Aliases / Synonyms
520-27-4; Barosmin; Diosimin; Flebosten; Venosmine; Diosmil; Diosmine; Daflon; Tovene
🧪 Chemistry
Molecular Weight
608.5490
LogP
-1.0897
Drug-likeness
0.159
H-Bond Acceptors
15
H-Bond Donors
8
Rotatable Bonds
7
🔬 Structures
Canonical SMILES
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
Isomeric SMILES
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
InChIKey
GZSOSUNBTXMUFQ-YFAPSIMESA-N
InChI
InChI=1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1
🔗 External References
🔍 Raw view — every non-empty column on this row (31 fields)
name
Diosmin
common names
520-27-4; Barosmin; Diosimin; Flebosten; Venosmine; Diosmil; Diosmine; Daflon; Tovene
herb ingredient id
HBIN024193
canonical smiles
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
isomeric smiles
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
inchi
InChI=1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1
inchikey
GZSOSUNBTXMUFQ-YFAPSIMESA-N
mol wt
608.5490
num h acceptors
15
num h donors
8
mol logp
-1.0897
num rotatable bonds
7
drug likeness
0.159
tcmid ingredient id
6453
tcmsp ingredient id
MOL005093
tcm id ingredient id
4839
pubchem cid
5281613
npass id
NPC209296
hit id
C0027
🏥 Linked Health Topics
2 · diseases via target pathways📋 Clinical Trials
6 · subject of clinical studyNCT01532882 Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in
→ Chronic Venous Disease of Lower Limbs
NCT02134249 Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome
→ Infertility
NCT03413618 Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
→ Deep Vein Thrombosis|Postthrombotic Syndrome
NCT03471910 Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in S
→ Venous Insufficiency
NCT05158192 Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Ref
→ Bioequivalence
NCT05243238 Hesperidin and Diosmin Effect on Metabolic Syndrome
→ Metabolic Syndrome and Diabetic Neuropathy
📊 Meta-Analyses
1 · systematic reviewCRD42017078018 Systematic review and meta-analysis of efficacy of diosmin and hesperidin versus
→ insufficiency venous
📚 PubMed References
7 · cited researchPMID 26361726 Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytok
Pharmacol Res
PMID 33302042 Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in
Phytomedicine
PMID 33744325 Targeting KEAP1/Nrf2, AKT, and PPAR-γ signals as a potential protective mechanis
Life Sci
PMID 33802633 Diosmin Mitigates Cyclophosphamide Induced Premature Ovarian Insufficiency in Ra
Int J Mol Sci
PMID 34638796 Diosmin Inhibits Glioblastoma Growth through Inhibition of Autophagic Flux
Int J Mol Sci
PMID 34943101 Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative
Antioxidants (Basel)
PMID 36139795 Diosmin and Trolox Have Anti-Arthritic, Anti-Inflammatory and Antioxidant Potenc
Antioxidants (Basel)
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables